• Cue Biopharma shares are trading 6.2% higher today at $29.50, buoyed by a $7.5 million milestone payment from Boehringer Ingelheim, which was reported on July 16, 2026.
  • This payment stems from a strategic collaboration and is a key factor in the stock's rebound.
  • The rally follows a recent multi-day pullback, which was influenced by the company's $50 million private placement that closed around July 13, causing dilution.